Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...
Blocked from reporting on U.S. Education Linda McMahon's visit to a Colts Neck school, the Asbury Park Press filed open ...
An efficient neural screening approach rapidly identifies circuit modules governing distinct behavioral transitions in response to pathogen exposure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results